Corebridge: Nippon Life buys 246,440 shares
A ten percent owner made the reported purchases under a Rule 10b5-1 plan adopted on August 7, 2026.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Filing Summary
Nippon Life Insurance Co., a ten percent owner of Corebridge Financial, Inc. (CRBD), purchased 246,440 common shares on October 22, 2026, at a weighted average price of $35.1523 per share. The purchases were made at prices ranging from $34.62 to $35.55 under a Rule 10b5-1 plan adopted August 7, 2026. Nippon Life reported 130,667,106 shares following the purchase, including shares held by its wholly owned subsidiary that Nippon Life may be deemed to beneficially own.
Insider Trade Summary 10b5-1
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Purchase | Common Stock F1, F2, F3 | 246,440 | $35.1523 | $8.66M |
Footnotes (3)
- F1. The purchases reported herein were effected pursuant to a Rule 10b5-1 plan adopted by the Reporting Person on August 7, 2026.
- F2. Includes 130,633,835 shares held of record by the Reporting Person and 33,271 shares held of record by Nissay Asset Management Corporation, a direct wholly owned subsidiary of the Reporting Person, which the Reporting Person may be deemed to beneficially own.
- F3. The price reported in Column 4 is a weighted average price. These shares were purchased in multiple transactions at prices ranging from $34.62 to $35.55, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range set forth herein.
Key Figures
Key Terms
Rule 10b5-1 plan regulatory
weighted average price financial
beneficially own regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
AI-generated analysis. How Rhea-AI works. Not financial advice.